Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon- related factor 1-dependent pathway

Journal of Experimental Medicine

Volumn 187, Issue 12, 1998, Pages 2023-2030

  Lechleitner, Sonja ^a   Gille, Jens ^b   Johnson, David R ^c   Petzelbauer, Peter ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b GOETHE UNIVERSITY   (Germany)

^c YALE UNIVERSITY   (United States)

Author keywords

Endothelium; Interferon; Interferon related factor 1; Skin microvasculature; Vascular cell adhesion molecule 1

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON RELATED FACTOR 1; INTERLEUKIN 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BINDING SITE; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

CELL COMPARTMENTATION; CELL NUCLEUS; DNA-BINDING PROTEINS; DRUG INTERACTIONS; E-SELECTIN; ENDOTHELIUM, VASCULAR; GENES, REPORTER; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERONS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SKIN; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032526580     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.12.2023     Document Type: Article

References (27)

1. Pelletier, R.P., R.G. Ohye, A. Vanbuskirk, D.D. Sedmak, P. Kincade, R.M. Ferguson, and C.G. Orosz. 1992. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J. Immunol. 149:2473-2481.
2. Orosz, C.G., R.G. Ohye, R.P. Pelletier, B.A. Van, E. Huang, C. Morgan, P.W. Kincade, and R.M. Ferguson. 1993. Treatment with anti-vascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance. Transplantation (Baltimore). 56:453-160.
3. Isobe, M., J. Suzuki, H. Yagita, K. Okumura, S. Yamazaki, R. Nagai, Y. Yazaki, and M. Sekiguchi. 1994. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies. J. Immunol. 153:5810-5818.
4. Nakajima, H., H. Sano, T. Nishimura, S. Yoshida, and I. Iwamoto. 1994. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Mol. 179:1145-1154.
5. Osborn, L., C. Hession, R. Tizard, C. Vassallo, S. Luhowskyj, R.G. Chi, and R. Lobb. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59:1203-1211.
6. Ahmad, M., N. Marui, R. W. Alexander, and R.M. Medford. 1995. Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif. J. Biol. Chem. 270:8976-8983.
7. Shu, H.B., A.B. Agranoff, E.G. Nabel, K. Leung, C.S. Duckett, A.S. Neish, T. Collins, and G.J. Nabel. 1993. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. Mol. Cell. Biol. 13:6283-6289.
8. Read, M.A., A.S. Neish, F.W. Luscinskas, V.J. Palombella, T. Maniatis, and T. Collins. 1995. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 2:493-506.
9. Lederer, J.A., J.S. Liou, S. Kim, N. Rice, and A.M. Lichtman. 1996. Regulation of NF-kappa B activation in T helper 1 and T helper 2 cells. J. Immunol. 156:56-63.
10. Read, M.A., M.Z. Whitley, A.J. Williams, and T. Collins. 1994. NF-κB and Iκbα: an inducible regulatory system in endothelial activation. J. Exp. Med. 179:503-512.
11. Neish, A.S., M.A. Read, D. Thanos, R. Pine, T. Maniatis, and T. Collins. 1995. Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol. Cell. Biol. 15:2558-2569.
12. Savage, C.O., C.J. Brooks, D. Adu, G. Richards, and A.J. Howie. 1997. Cell adhesion molecule expression within human glomerular and kidney organ culture. J. Pathol. 181: 111-115.
13. Petzelbauer, P., J.R. Bender, J. Wilson, and J.S. Pober. 1993. Heterogeneity of dermal micro vascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J. Immunol. 151:5062-5072.
14. Pall, A.A., A.J. Howie, D. Adu, G.M. Richards, C.D. Inward, D.V. Milford, N.T. Richards, J. Michael, and C.M. Taylor. 1996. Glomerular vascular cell adhesion molecule-1 expression in renal vasculitis. J. Clin. Pathol. 49:238-242.
15. Petzelbauer, P., J.S. Pober, A. Keh, and I.M. Braverman. 1994. Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. J. Invest. Dermatol. 103:300-305.
16. Iademarco, M.F., J.J. McQuillan, G.D. Rosen, and D.C. Dean. 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267: 16323-16329.
17. Neish, A.S., A.J. Williams, H.J. Palmer, M.Z. Whitley, and T. Collins. 1992. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J. Exp. Med. 176:1583-1593.
18. Neish, A.S., L.M. Khachigian, A. Park, V.R. Baichwal, and T. Collins. 1995. Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1. J. Biol. Chem. 270:28903-28909.
19. Ten, R.M., V. Blank, B.O. Le, P. Kourilsky, and A. Israel. 1993. Two factors, IRF1 and KBF1/NF-kappa B, cooperate during induction of MHC class I gene expression by interferon alpha beta or Newcastle disease virus. C. R. Acad. Sci. III. 316:496-501.
20. + T cells migrate through superficial vascular plexus but not through deep vascular plexus endothelium. J. Invest. Dermatol. 108:343-348.
21. Gille, J., R.A. Swerlick, T.J. Lawley, and S.W. Caughman, 1996. Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood. 87:211-217.
22. Harada, H., K. Willison, J. Sakakibara, M. Miyamoto, T. Fujita, and T. Taniguchi. 1990. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell. 63:303-312.
23. Fujita, T., Y. Kimura, M. Miyamoto, E.L. Barsoumian, and T. Taniguchi. 1989. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature. 337:270-272.
24. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:729-739.
25. Saffer, J.D., S.P. Jackson, and M.B. Annarella. 1991. Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11: 2189-2199.
26. Iademarco, M.F., J.J. McQuillan, and D.C. Dean. 1993. Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Proc. Natl. Acad. Sci. USA. 90:3943-3947.
27. Hauser, I.A., D.R. Johnson, and J.A. Madri. 1993. Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion. J. Immunol. 151: 5172-5185.